NCCAM GUIDELINES FOR INVESTIGATOR-INITIATED APPLICATIONS

Release Date:  January 29, 1999

P.T.

National Center for Complementary and Alternative Medicine

PURPOSE

"The general purposes of the National Center for Complementary and Alternative
Medicine (NCCAM) are the conduct and support of basic and applied research . .
. research training, . . . and other programs with respect to identifying,
investigating, and validating complementary and alternative treatment,
diagnostic, and prevention modalities, disciples and systems" (P.L. 105-277). 
In order to meet this congressional mandate, NCCAM is accepting investigator-
initiated applications for all types of research (e.g., basic, clinical,
epidemiological and health services) using the following award mechanisms:

F31   Pre-doctoral Individual National Research Service Awards
F32   Post-doctoral Individual National Research Service Awards
K01   Research Scientist Development Award
K02   Independent Scientist Award
K07   Academic Career Award
K08   Mentored Clinical Scientist Development Award
K12   Mentored Clinical Scientist Development Award Program
K22   Career Transition Award
K23   Mentored Patient-Oriented Research Career Development Award
K24   Midcareer Investigator Award in Patient-Oriented Research
P01   Research Program Project grants (restrictions apply - see below)
R01   Research Project (Traditional) (restrictions apply to Phase III Clinical
Trials - see below)
R15   Academic Research Enhancement Award
R21   Exploratory/Developmental grants (restrictions apply -see below)
R41   Small Business Technology Transfer Grant (STTR) - Phase I
R42   Small Business Technology Transfer Grant (STTR) - Phase II
R43   Small Business Innovation Research Grant (SBIR) - Phase I
R44   Small Business Innovation Research Grant (SBIR) - Phase II
T32   Institutional National Research Service Award

Applications for these awards should follow standard National Institute of
Health guidelines and receipt dates.  Application kits are available at most
institutional offices of sponsored research and also may be obtained from the
Division of Extramural Outreach and Information Resources, National Institutes
of Health, 6701 Rockledge Drive, MSC 7910, Bethesda, MD 20892-7910, telephone:
301-710-0267, email: [email protected].  Applications are also available on
the World Wide Web at https://grants.nih.gov/grants/forms.htm.

Applications for Phase III clinical trials, for Research Program Project
grants (P01), for Exploratory/Developmental grants (R21) or for any grant in
excess of $500,000 direct costs in one or more years of the award require
prior approval by NCCAM.  In reference to the above, applications received
without an indication of prior NCCAM concurrence and identification of the
NCCAM contact will be returned to the applicant without review. (refer to
"Acceptance for Review of Unsolicited Applications That Request More Than
$500,000 Direct Costs," NIH Guide, March 20, 1998)

For the purposes of this Notice, NCCAM defines Phase III clinical trials as
the following:  A Phase III trial is a broadly based prospective investigation
usually involving a substantial number of human subjects.  The primary
objective of such trials is to evaluate an experimental intervention in
comparison with a standard or control intervention, or to compare two or more
existing treatments.  The definition includes interventions given for disease
prevention, prophylaxis, diagnosis, or therapy.  Community trials and other
population-based intervention trials are also included.

INQUIRES

Individuals interested in learning about current NCCAM program areas and
initiatives, including guidelines for Research Program Project grants (P01),
Exploratory/Developmental grants (R21) and Phase III Clinical trials, are
encouraged to visit the NCCAM Internet site (http://altmed.od.nih.gov) or to
contact the Center directly.

National Center for Complementary and Alternative Medicine
Division of Extramural Research, Training and Review
National Institutes of Health
31 Center Drive, Room 5B-36
Bethesda, MD  20892-2182
Telephone:  (301) 402-2466
FAX:  (301) 402-4741

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)